Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia

NJ Chao(Stanford University), KG Blume(Stanford University), RS Negrin(Stanford University), MD Amylon(City Of Hope National Medical Center), GD Long(Stanford University), RM Wong(Stanford University), SJ Forman(City Of Hope National Medical Center), AS Stein(Stanford University)
Blood
January 15, 1993
10.1182/blood.v81.2.319.bloodjournal812319
Cited by 4

Related Papers

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
|The Journal of Experimental Medicine|1991|623
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
|Blood|1993|284
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy
|Blood|1996|209
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells
|Blood|1995|127
Dynamic assessment of quality of life after autologous bone marrow transplantation
|Blood|1992|111